Assignee
VIFOR INT AG
CH·14 granted patents·20 pending applications·148 citations·filing 1996–2024
Top patents by PatentIndex Score
34 records- 0193US7612109B2Water-soluble iron-carbohydrate complexes, production thereof, and medicaments containing said complexesVIFOR INT AG·Filed 2003·Granted Nov 3, 2009·34 cites·27 claims
- 0293US6174442B1Adsorbent for phosphate from an aqueous medium, production and use of said adsorbentVIFOR INT AG·Filed 1996·Granted Jan 16, 2001·98 cites·14 claims
- 0391US10519252B2Aqueous iron carbohydrate complexes, their production and medicaments containing themVIFOR INT AG·Filed 2013·Granted Dec 31, 2019·5 cites·26 claims
- 0490US10364239B2Ferroportin inhibitorsVIFOR INT AG·Filed 2016·Granted Jul 30, 2019·6 cites·21 claims
- 0587US11291645B2Aqueous iron carbohydrate complexes, their production and medicaments containing themVIFOR INT AG·Filed 2020·Granted Apr 5, 2022·1 cites·21 claims
- 0687US11123321B2Aqueous iron carbohydrate complexes, their production and medicaments containing themVIFOR INT AG·Filed 2020·Granted Sep 21, 2021·1 cites·29 claims
- 0785US2022387371A1Aqueous iron carbohydrate complexes, their production and medicaments containing themVIFOR INT AG·Filed 2022·Application pending·0 cites
- 0881US2024336640A1Calcium oxalate crystallization inhibitors for renal disordersVIFOR INT AG·Filed 2024·Application pending·0 cites
- 0974US11590097B2Aqueous iron carbohydrate complexes, their production and medicaments containing themVIFOR INT AG·Filed 2019·Granted Feb 28, 2023·0 cites·17 claims
- 1074US2010099647A1Aqueous Iron Carbohydrate Complexes, Their Production And Medicaments Containing ThemVIFOR INT AG·Filed 2009·Application pending·0 cites
- 1173US11129820B2Ferroportin-inhibitor saltsVIFOR INT AG·Filed 2018·Granted Sep 28, 2021·2 cites·26 claims
- 1273US2014371169A1Aqueous iron carbohydrate complexes, their production and medicaments containing themVIFOR INT AG·Filed 2014·Application pending·0 cites
- 1372US11066399B2Ferroportin inhibitorsVIFOR INT AG·Filed 2020·Granted Jul 20, 2021·0 cites·6 claims
- 1471US2022363675A1Novel Ferroportin InhibitorsVIFOR INT AG·Filed 2021·Application pending·0 cites
- 1568US11001579B2Ferroportin inhibitorsVIFOR INT AG·Filed 2019·Granted May 11, 2021·0 cites·11 claims
- 1664US9102688B2Sulfonaminoquinoline hepcidin antagonistsVIFOR INT AG·Filed 2014·Granted Aug 11, 2015·1 cites·16 claims
- 1761US2014335202A1Iron Sulfate-Based Phosphate AdsorbentVIFOR INT AG·Filed 2014·Application pending·0 cites
- 1856US2024100074A1Clinical Dosing Schedule of Inositol Phosphate Oligo(Ethylene Glycol) CompoundsVIFOR INT AG·Filed 2022·Application pending·0 cites
- 1956US2010294791A1Tablet DispenserVIFOR INT AG·Filed 2008·Application pending·0 cites
- 2055US2023212159A1Process for the Production of Ferroportin InhibitorsVIFOR INT AG·Filed 2021·Application pending·0 cites
- 2155US2024343722A1N-substituted ferroportin inhibitorsVIFOR INT AG·Filed 2022·Application pending·0 cites
- 2253US2024239780A1Modified ferroportin inhibitorsVIFOR INT AG·Filed 2022·Application pending·0 cites
- 2353US2025268878A1Ferroportin-inhibitors for the use in the treatment of myelodysplastic syndromes (mds)VIFOR INT AG·Filed 2022·Application pending·0 cites
- 2451US2008269167A1Preparation Comprising Iron(III) Complex Compounds And Redox-Active Substance(s)VIFOR INT AG·Filed 2006·Application pending·0 cites
- 2550US9248134B1Fe(III) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemiasVIFOR INT AG·Filed 2014·Granted Feb 2, 2016·0 cites·15 claims
- 2648US2022323416A1Ferroportin-Inhibitors For The Use In The Prevention And Treatment Of Kidney InjuriesVIFOR INT AG·Filed 2020·Application pending·0 cites
- 2748US2013157974A1Preparation Comprising Iron(III) Complex Compounds And Redox-Active Substance(s)VIFOR INT AG·Filed 2013·Application pending·0 cites
- 2848US2009169645A1Iron Sulfate-Based Phosphate AdsorbentVIFOR INT AG·Filed 2005·Application pending·0 cites
- 2948US2022054540A1Ferric Carboxymaltose In The Treatment Of Heart Failure And In The Treatment Of Congestion In Heart FailureVIFOR INT AG·Filed 2019·Application pending·0 cites
- 3044US2022274973A1Methods And Compositions For Treating Sickle Cell Disease With A Ferroportin Inhibitor (VIT-2763)VIFOR INT AG·Filed 2020·Application pending·0 cites
- 3143US9943498B2Fe(III) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemiasVIFOR INT AG·Filed 2016·Granted Apr 17, 2018·0 cites·12 claims
- 3243US2008299285A1Process For The Preparation Of Ferri-SuccinylcaseinVIFOR INT AG·Filed 2006·Application pending·0 cites
- 3340US12533348B2Ferroportin-inhibitors for the use in the treatment of transfusion-dependent beta-thalassemia (TDT)VIFOR INT AG·Filed 2020·Granted Jan 27, 2026·0 cites·18 claims
- 3437US2008234226A1Use Of Iron(III) Complex Compounds For The Preparation Of A Medicament For Oral Treatment Of Iron Deficiency States In Patients With Chronic Inflammatory Bowel DiseaseVIFOR INT AG·Filed 2006·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →